USPTO serial 97858672
REGENMATRIX
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLARK, MICHAEL J.
- Law office
- TMO LAW OFFICE 133
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with REGENMATRIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Brooklyn, NY, US
Jersey City, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Kaplan
P.O. Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics, namely, beauty masks, cosmetic kits comprising primarily of lotions, creams, and preparations for skin care, cosmetic creams, lotions for cosmetic purposes, cosmetic lotions, cosmetic preparations for skin care, pomades for cosmetic purposes, tissues impregnated with cosmetic lotions, cotton buds for cosmetic purposes, cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care, non-medicated preparations for skin care, namely, skin serum not for medical use, skin care preparations, namely, non-medicated skin serum, non-medicated stimulating lotions for the skin, anti-wrinkle cream for skin care, non-medicated anti-aging serum | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for the treatment of musculoskeletal, skin, urological and urogenital diseases and conditions, arthritis, and wound care; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions for medical purposes; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use; all the foregoing relating to the use of blood derived ingredients in regenerative therapies. | ACTIVE | — |
| 010 | Surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology and mesotherapy; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; suture material; syringes for injections; cases fitted for medical instruments; receptacles for applying medicines, namely, bottles, jars, containers, canuale, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; cases fitted for medical instruments for use by surgeons or doctors; medical injection instruments with needles; medical injection instruments without needles; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; surgical and medical apparatus and instruments used in general surgery; medical apparatus used for taking blood; medical apparatus used for taking blood samples; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical instruments, namely, surgical instruments for biological tissue; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels; all the foregoing relating to the use of blood derived ingredients in regenerative therapies. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 27, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 26, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 26, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 26, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 24, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 24, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 24, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 13, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 12, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 12, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 12, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 26, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 13, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 11, 2024 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 3, 2024 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 21, 2024 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 20, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 4, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 15, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 1, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 1, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 1, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 1, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 19, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 19, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 19, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 22, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 30, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 18, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 30, 2023 | NWAP | NEW APPLICATION ENTERED | — |